nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—Cloperastine—Raloxifene—osteoporosis	0.339	1	CrCrCtD
Carbinoxamine—CYP2B6—Raloxifene—osteoporosis	0.0513	0.0943	CbGbCtD
Carbinoxamine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0495	0.091	CbGbCtD
Carbinoxamine—CYP2C9—Estropipate—osteoporosis	0.0406	0.0746	CbGbCtD
Carbinoxamine—CYP2B6—Cholecalciferol—osteoporosis	0.0396	0.0728	CbGbCtD
Carbinoxamine—CYP2C8—Raloxifene—osteoporosis	0.0388	0.0714	CbGbCtD
Carbinoxamine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0375	0.069	CbGbCtD
Carbinoxamine—CYP2C8—Cholecalciferol—osteoporosis	0.03	0.0551	CbGbCtD
Carbinoxamine—CYP2C19—Cholecalciferol—osteoporosis	0.0251	0.0462	CbGbCtD
Carbinoxamine—CYP2C8—Estradiol—osteoporosis	0.0242	0.0444	CbGbCtD
Carbinoxamine—CYP3A4—Estropipate—osteoporosis	0.0236	0.0434	CbGbCtD
Carbinoxamine—CYP3A4—Calcitriol—osteoporosis	0.0236	0.0434	CbGbCtD
Carbinoxamine—CYP2C9—Cholecalciferol—osteoporosis	0.0209	0.0384	CbGbCtD
Carbinoxamine—CYP2C19—Estradiol—osteoporosis	0.0203	0.0373	CbGbCtD
Carbinoxamine—CYP2D6—Cholecalciferol—osteoporosis	0.0191	0.0352	CbGbCtD
Carbinoxamine—CYP3A4—Ergocalciferol—osteoporosis	0.0189	0.0347	CbGbCtD
Carbinoxamine—CYP2C9—Estradiol—osteoporosis	0.0169	0.031	CbGbCtD
Carbinoxamine—CYP3A4—Raloxifene—osteoporosis	0.0157	0.029	CbGbCtD
Carbinoxamine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0152	0.028	CbGbCtD
Carbinoxamine—CYP3A4—Cholecalciferol—osteoporosis	0.0122	0.0224	CbGbCtD
Carbinoxamine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0112	0.0205	CbGbCtD
Carbinoxamine—CYP3A4—Estradiol—osteoporosis	0.0098	0.018	CbGbCtD
Carbinoxamine—Photosensitivity—Alendronate—osteoporosis	0.00124	0.0108	CcSEcCtD
Carbinoxamine—Neuritis—Estradiol—osteoporosis	0.00108	0.00941	CcSEcCtD
Carbinoxamine—Irritability—Estropipate—osteoporosis	0.00106	0.0092	CcSEcCtD
Carbinoxamine—Urinary retention—Ibandronate—osteoporosis	0.00101	0.00879	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Etidronic acid—osteoporosis	0.000966	0.00842	CcSEcCtD
Carbinoxamine—Confusional state—Calcium Acetate—osteoporosis	0.000966	0.00841	CcSEcCtD
Carbinoxamine—Agranulocytosis—Etidronic acid—osteoporosis	0.00092	0.00801	CcSEcCtD
Carbinoxamine—Anorexia—Calcium Acetate—osteoporosis	0.000913	0.00795	CcSEcCtD
Carbinoxamine—Chest discomfort—Estradiol—osteoporosis	0.000911	0.00794	CcSEcCtD
Carbinoxamine—Hypotension—Calcium Acetate—osteoporosis	0.000895	0.0078	CcSEcCtD
Carbinoxamine—Paraesthesia—Calcium Acetate—osteoporosis	0.00086	0.00749	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Alendronate—osteoporosis	0.00086	0.00749	CcSEcCtD
Carbinoxamine—Irritability—Ethinyl Estradiol—osteoporosis	0.000856	0.00746	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Estropipate—osteoporosis	0.000836	0.00728	CcSEcCtD
Carbinoxamine—Decreased appetite—Calcium Acetate—osteoporosis	0.000832	0.00725	CcSEcCtD
Carbinoxamine—Constipation—Calcium Acetate—osteoporosis	0.000819	0.00713	CcSEcCtD
Carbinoxamine—Anorexia—Ergocalciferol—osteoporosis	0.000806	0.00703	CcSEcCtD
Carbinoxamine—Drowsiness—Calcitriol—osteoporosis	0.000801	0.00697	CcSEcCtD
Carbinoxamine—Mitotane—SHBG—osteoporosis	0.000798	1	CrCbGaD
Carbinoxamine—Feeling abnormal—Calcium Acetate—osteoporosis	0.000789	0.00688	CcSEcCtD
Carbinoxamine—Decreased appetite—Ergocalciferol—osteoporosis	0.000735	0.00641	CcSEcCtD
Carbinoxamine—Constipation—Ergocalciferol—osteoporosis	0.000723	0.0063	CcSEcCtD
Carbinoxamine—Pollakiuria—Ethinyl Estradiol—osteoporosis	0.000716	0.00624	CcSEcCtD
Carbinoxamine—Sweating increased—Pamidronate—osteoporosis	0.0007	0.0061	CcSEcCtD
Carbinoxamine—Irritability—Conjugated Estrogens—osteoporosis	0.000698	0.00608	CcSEcCtD
Carbinoxamine—Asthenia—Calcium Acetate—osteoporosis	0.000687	0.00599	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.000678	0.0059	CcSEcCtD
Carbinoxamine—Chills—Ibandronate—osteoporosis	0.000659	0.00574	CcSEcCtD
Carbinoxamine—Diarrhoea—Calcium Acetate—osteoporosis	0.000655	0.00571	CcSEcCtD
Carbinoxamine—Tension—Estropipate—osteoporosis	0.000654	0.0057	CcSEcCtD
Carbinoxamine—Nervousness—Estropipate—osteoporosis	0.000647	0.00564	CcSEcCtD
Carbinoxamine—Nasal congestion—Estradiol—osteoporosis	0.000642	0.0056	CcSEcCtD
Carbinoxamine—Sweating increased—Zoledronate—osteoporosis	0.000639	0.00557	CcSEcCtD
Carbinoxamine—Confusional state—Etidronic acid—osteoporosis	0.000634	0.00552	CcSEcCtD
Carbinoxamine—Dizziness—Calcium Acetate—osteoporosis	0.000633	0.00552	CcSEcCtD
Carbinoxamine—Sweating increased—Conjugated Estrogens—osteoporosis	0.000616	0.00536	CcSEcCtD
Carbinoxamine—Vomiting—Calcium Acetate—osteoporosis	0.000609	0.0053	CcSEcCtD
Carbinoxamine—Asthenia—Ergocalciferol—osteoporosis	0.000607	0.00529	CcSEcCtD
Carbinoxamine—Pollakiuria—Zoledronate—osteoporosis	0.000606	0.00528	CcSEcCtD
Carbinoxamine—Vertigo—Estropipate—osteoporosis	0.000599	0.00522	CcSEcCtD
Carbinoxamine—Agranulocytosis—Pamidronate—osteoporosis	0.000598	0.00521	CcSEcCtD
Carbinoxamine—Vertigo—Alendronate—osteoporosis	0.00059	0.00514	CcSEcCtD
Carbinoxamine—Palpitations—Estropipate—osteoporosis	0.000589	0.00513	CcSEcCtD
Carbinoxamine—Vertigo—Raloxifene—osteoporosis	0.00058	0.00505	CcSEcCtD
Carbinoxamine—Agitation—Calcitriol—osteoporosis	0.000575	0.00501	CcSEcCtD
Carbinoxamine—Vertigo—Ibandronate—osteoporosis	0.000574	0.005	CcSEcCtD
Carbinoxamine—Nausea—Calcium Acetate—osteoporosis	0.000569	0.00496	CcSEcCtD
Carbinoxamine—Palpitations—Ibandronate—osteoporosis	0.000565	0.00492	CcSEcCtD
Carbinoxamine—Paraesthesia—Etidronic acid—osteoporosis	0.000565	0.00492	CcSEcCtD
Carbinoxamine—Tinnitus—Risedronate—osteoporosis	0.000564	0.00491	CcSEcCtD
Carbinoxamine—Irritability—Estradiol—osteoporosis	0.000559	0.00487	CcSEcCtD
Carbinoxamine—Dyspepsia—Etidronic acid—osteoporosis	0.000553	0.00482	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.000552	0.00481	CcSEcCtD
Carbinoxamine—Agranulocytosis—Zoledronate—osteoporosis	0.000546	0.00476	CcSEcCtD
Carbinoxamine—Convulsion—Calcitriol—osteoporosis	0.000542	0.00472	CcSEcCtD
Carbinoxamine—Constipation—Etidronic acid—osteoporosis	0.000538	0.00468	CcSEcCtD
Carbinoxamine—Feeling abnormal—Etidronic acid—osteoporosis	0.000518	0.00451	CcSEcCtD
Carbinoxamine—Chills—Pamidronate—osteoporosis	0.000516	0.0045	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Raloxifene—osteoporosis	0.000516	0.00449	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Raloxifene—osteoporosis	0.000509	0.00444	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Ibandronate—osteoporosis	0.000504	0.00439	CcSEcCtD
Carbinoxamine—Nausea—Ergocalciferol—osteoporosis	0.000502	0.00438	CcSEcCtD
Carbinoxamine—Urticaria—Etidronic acid—osteoporosis	0.000499	0.00435	CcSEcCtD
Carbinoxamine—Sweating increased—Estradiol—osteoporosis	0.000493	0.00429	CcSEcCtD
Carbinoxamine—Insomnia—Estropipate—osteoporosis	0.000492	0.00429	CcSEcCtD
Carbinoxamine—Tension—Pamidronate—osteoporosis	0.000491	0.00428	CcSEcCtD
Carbinoxamine—Paraesthesia—Estropipate—osteoporosis	0.000488	0.00426	CcSEcCtD
Carbinoxamine—Anorexia—Calcitriol—osteoporosis	0.000487	0.00424	CcSEcCtD
Carbinoxamine—Nervousness—Pamidronate—osteoporosis	0.000486	0.00424	CcSEcCtD
Carbinoxamine—Somnolence—Estropipate—osteoporosis	0.000484	0.00421	CcSEcCtD
Carbinoxamine—Dyspepsia—Estropipate—osteoporosis	0.000479	0.00417	CcSEcCtD
Carbinoxamine—Insomnia—Raloxifene—osteoporosis	0.000477	0.00415	CcSEcCtD
Carbinoxamine—Vertigo—Risedronate—osteoporosis	0.000473	0.00412	CcSEcCtD
Carbinoxamine—Insomnia—Ibandronate—osteoporosis	0.000472	0.00411	CcSEcCtD
Carbinoxamine—Dyspepsia—Alendronate—osteoporosis	0.000472	0.00411	CcSEcCtD
Carbinoxamine—Chills—Zoledronate—osteoporosis	0.000471	0.00411	CcSEcCtD
Carbinoxamine—Fatigue—Estropipate—osteoporosis	0.000469	0.00409	CcSEcCtD
Carbinoxamine—Paraesthesia—Ibandronate—osteoporosis	0.000468	0.00408	CcSEcCtD
Carbinoxamine—Pollakiuria—Estradiol—osteoporosis	0.000467	0.00407	CcSEcCtD
Carbinoxamine—Constipation—Estropipate—osteoporosis	0.000465	0.00405	CcSEcCtD
Carbinoxamine—Dyspepsia—Raloxifene—osteoporosis	0.000464	0.00404	CcSEcCtD
Carbinoxamine—Insomnia—Calcitriol—osteoporosis	0.000462	0.00402	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Estradiol—osteoporosis	0.000462	0.00402	CcSEcCtD
Carbinoxamine—Agitation—Pamidronate—osteoporosis	0.00046	0.00401	CcSEcCtD
Carbinoxamine—Dyspepsia—Ibandronate—osteoporosis	0.000459	0.004	CcSEcCtD
Carbinoxamine—Constipation—Alendronate—osteoporosis	0.000458	0.00399	CcSEcCtD
Carbinoxamine—Somnolence—Calcitriol—osteoporosis	0.000454	0.00395	CcSEcCtD
Carbinoxamine—Decreased appetite—Ibandronate—osteoporosis	0.000453	0.00395	CcSEcCtD
Carbinoxamine—Fatigue—Ibandronate—osteoporosis	0.00045	0.00392	CcSEcCtD
Carbinoxamine—Constipation—Ibandronate—osteoporosis	0.000446	0.00389	CcSEcCtD
Carbinoxamine—Decreased appetite—Calcitriol—osteoporosis	0.000444	0.00387	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Estradiol—osteoporosis	0.000442	0.00385	CcSEcCtD
Carbinoxamine—Feeling abnormal—Alendronate—osteoporosis	0.000441	0.00385	CcSEcCtD
Carbinoxamine—Constipation—Calcitriol—osteoporosis	0.000437	0.0038	CcSEcCtD
Carbinoxamine—Convulsion—Pamidronate—osteoporosis	0.000434	0.00378	CcSEcCtD
Carbinoxamine—Tension—Conjugated Estrogens—osteoporosis	0.000432	0.00376	CcSEcCtD
Carbinoxamine—Urticaria—Estropipate—osteoporosis	0.000432	0.00376	CcSEcCtD
Carbinoxamine—Vision blurred—Zoledronate—osteoporosis	0.000431	0.00376	CcSEcCtD
Carbinoxamine—Diarrhoea—Etidronic acid—osteoporosis	0.00043	0.00375	CcSEcCtD
Carbinoxamine—Feeling abnormal—Ibandronate—osteoporosis	0.00043	0.00374	CcSEcCtD
Carbinoxamine—Tremor—Zoledronate—osteoporosis	0.000428	0.00373	CcSEcCtD
Carbinoxamine—Nervousness—Conjugated Estrogens—osteoporosis	0.000428	0.00373	CcSEcCtD
Carbinoxamine—Urticaria—Alendronate—osteoporosis	0.000426	0.00371	CcSEcCtD
Carbinoxamine—Agitation—Zoledronate—osteoporosis	0.00042	0.00366	CcSEcCtD
Carbinoxamine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000415	0.00362	CcSEcCtD
Carbinoxamine—Urticaria—Ibandronate—osteoporosis	0.000414	0.00361	CcSEcCtD
Carbinoxamine—Confusional state—Pamidronate—osteoporosis	0.000412	0.00359	CcSEcCtD
Carbinoxamine—Vertigo—Zoledronate—osteoporosis	0.000411	0.00358	CcSEcCtD
Carbinoxamine—Urticaria—Calcitriol—osteoporosis	0.000406	0.00353	CcSEcCtD
Carbinoxamine—Palpitations—Zoledronate—osteoporosis	0.000404	0.00352	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Pamidronate—osteoporosis	0.0004	0.00349	CcSEcCtD
Carbinoxamine—Vomiting—Etidronic acid—osteoporosis	0.0004	0.00348	CcSEcCtD
Carbinoxamine—Tachycardia—Pamidronate—osteoporosis	0.000399	0.00347	CcSEcCtD
Carbinoxamine—Convulsion—Zoledronate—osteoporosis	0.000396	0.00345	CcSEcCtD
Carbinoxamine—Vertigo—Conjugated Estrogens—osteoporosis	0.000396	0.00345	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Pamidronate—osteoporosis	0.000395	0.00344	CcSEcCtD
Carbinoxamine—Headache—Etidronic acid—osteoporosis	0.000394	0.00343	CcSEcCtD
Carbinoxamine—Asthenia—Estropipate—osteoporosis	0.00039	0.0034	CcSEcCtD
Carbinoxamine—Anorexia—Pamidronate—osteoporosis	0.000389	0.00339	CcSEcCtD
Carbinoxamine—Palpitations—Conjugated Estrogens—osteoporosis	0.000389	0.00339	CcSEcCtD
Carbinoxamine—Insomnia—Risedronate—osteoporosis	0.000389	0.00339	CcSEcCtD
Carbinoxamine—Paraesthesia—Risedronate—osteoporosis	0.000386	0.00336	CcSEcCtD
Carbinoxamine—Asthenia—Alendronate—osteoporosis	0.000384	0.00335	CcSEcCtD
Carbinoxamine—Hypotension—Pamidronate—osteoporosis	0.000382	0.00333	CcSEcCtD
Carbinoxamine—Convulsion—Conjugated Estrogens—osteoporosis	0.000382	0.00332	CcSEcCtD
Carbinoxamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00038	0.00331	CcSEcCtD
Carbinoxamine—Dyspepsia—Risedronate—osteoporosis	0.000378	0.0033	CcSEcCtD
Carbinoxamine—Tinnitus—Estradiol—osteoporosis	0.000377	0.00329	CcSEcCtD
Carbinoxamine—Constipation—Ethinyl Estradiol—osteoporosis	0.000377	0.00328	CcSEcCtD
Carbinoxamine—Confusional state—Zoledronate—osteoporosis	0.000376	0.00328	CcSEcCtD
Carbinoxamine—Asthenia—Ibandronate—osteoporosis	0.000374	0.00326	CcSEcCtD
Carbinoxamine—Nausea—Etidronic acid—osteoporosis	0.000373	0.00325	CcSEcCtD
Carbinoxamine—Diarrhoea—Estropipate—osteoporosis	0.000372	0.00324	CcSEcCtD
Carbinoxamine—Fatigue—Risedronate—osteoporosis	0.000371	0.00323	CcSEcCtD
Carbinoxamine—Insomnia—Pamidronate—osteoporosis	0.00037	0.00322	CcSEcCtD
Carbinoxamine—Constipation—Risedronate—osteoporosis	0.000368	0.0032	CcSEcCtD
Carbinoxamine—Paraesthesia—Pamidronate—osteoporosis	0.000367	0.0032	CcSEcCtD
Carbinoxamine—Diarrhoea—Alendronate—osteoporosis	0.000367	0.00319	CcSEcCtD
Carbinoxamine—Asthenia—Calcitriol—osteoporosis	0.000366	0.00319	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Zoledronate—osteoporosis	0.000365	0.00318	CcSEcCtD
Carbinoxamine—Tachycardia—Zoledronate—osteoporosis	0.000364	0.00317	CcSEcCtD
Carbinoxamine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000363	0.00317	CcSEcCtD
Carbinoxamine—Chills—Estradiol—osteoporosis	0.000363	0.00316	CcSEcCtD
Carbinoxamine—Somnolence—Pamidronate—osteoporosis	0.000363	0.00316	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Zoledronate—osteoporosis	0.000361	0.00314	CcSEcCtD
Carbinoxamine—Diarrhoea—Raloxifene—osteoporosis	0.00036	0.00314	CcSEcCtD
Carbinoxamine—Dyspepsia—Pamidronate—osteoporosis	0.00036	0.00313	CcSEcCtD
Carbinoxamine—Dizziness—Estropipate—osteoporosis	0.00036	0.00313	CcSEcCtD
Carbinoxamine—Diarrhoea—Ibandronate—osteoporosis	0.000357	0.00311	CcSEcCtD
Carbinoxamine—Anorexia—Zoledronate—osteoporosis	0.000356	0.0031	CcSEcCtD
Carbinoxamine—Decreased appetite—Pamidronate—osteoporosis	0.000355	0.00309	CcSEcCtD
Carbinoxamine—Dizziness—Alendronate—osteoporosis	0.000354	0.00309	CcSEcCtD
Carbinoxamine—Fatigue—Pamidronate—osteoporosis	0.000352	0.00307	CcSEcCtD
Carbinoxamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000351	0.00306	CcSEcCtD
Carbinoxamine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00035	0.00305	CcSEcCtD
Carbinoxamine—Constipation—Pamidronate—osteoporosis	0.000349	0.00304	CcSEcCtD
Carbinoxamine—Diarrhoea—Calcitriol—osteoporosis	0.000349	0.00304	CcSEcCtD
Carbinoxamine—Hypotension—Zoledronate—osteoporosis	0.000349	0.00304	CcSEcCtD
Carbinoxamine—Dizziness—Raloxifene—osteoporosis	0.000348	0.00304	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000347	0.00303	CcSEcCtD
Carbinoxamine—Tension—Estradiol—osteoporosis	0.000346	0.00301	CcSEcCtD
Carbinoxamine—Vomiting—Estropipate—osteoporosis	0.000346	0.00301	CcSEcCtD
Carbinoxamine—Dizziness—Ibandronate—osteoporosis	0.000345	0.003	CcSEcCtD
Carbinoxamine—Anorexia—Conjugated Estrogens—osteoporosis	0.000343	0.00298	CcSEcCtD
Carbinoxamine—Nervousness—Estradiol—osteoporosis	0.000342	0.00298	CcSEcCtD
Carbinoxamine—Urticaria—Risedronate—osteoporosis	0.000341	0.00298	CcSEcCtD
Carbinoxamine—Headache—Estropipate—osteoporosis	0.000341	0.00297	CcSEcCtD
Carbinoxamine—Vomiting—Alendronate—osteoporosis	0.000341	0.00297	CcSEcCtD
Carbinoxamine—Insomnia—Zoledronate—osteoporosis	0.000338	0.00294	CcSEcCtD
Carbinoxamine—Feeling abnormal—Pamidronate—osteoporosis	0.000337	0.00293	CcSEcCtD
Carbinoxamine—Hypotension—Conjugated Estrogens—osteoporosis	0.000336	0.00293	CcSEcCtD
Carbinoxamine—Headache—Alendronate—osteoporosis	0.000336	0.00292	CcSEcCtD
Carbinoxamine—Paraesthesia—Zoledronate—osteoporosis	0.000335	0.00292	CcSEcCtD
Carbinoxamine—Vomiting—Raloxifene—osteoporosis	0.000335	0.00292	CcSEcCtD
Carbinoxamine—Somnolence—Zoledronate—osteoporosis	0.000332	0.00289	CcSEcCtD
Carbinoxamine—Vomiting—Ibandronate—osteoporosis	0.000332	0.00289	CcSEcCtD
Carbinoxamine—Tremor—Estradiol—osteoporosis	0.00033	0.00288	CcSEcCtD
Carbinoxamine—Headache—Raloxifene—osteoporosis	0.00033	0.00288	CcSEcCtD
Carbinoxamine—Dyspepsia—Zoledronate—osteoporosis	0.000329	0.00286	CcSEcCtD
Carbinoxamine—Headache—Ibandronate—osteoporosis	0.000327	0.00285	CcSEcCtD
Carbinoxamine—Insomnia—Conjugated Estrogens—osteoporosis	0.000325	0.00283	CcSEcCtD
Carbinoxamine—Vomiting—Calcitriol—osteoporosis	0.000325	0.00283	CcSEcCtD
Carbinoxamine—Decreased appetite—Zoledronate—osteoporosis	0.000324	0.00283	CcSEcCtD
Carbinoxamine—Agitation—Estradiol—osteoporosis	0.000324	0.00282	CcSEcCtD
Carbinoxamine—Nausea—Estropipate—osteoporosis	0.000323	0.00281	CcSEcCtD
Carbinoxamine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000323	0.00281	CcSEcCtD
Carbinoxamine—Fatigue—Zoledronate—osteoporosis	0.000322	0.0028	CcSEcCtD
Carbinoxamine—Headache—Calcitriol—osteoporosis	0.00032	0.00279	CcSEcCtD
Carbinoxamine—Somnolence—Conjugated Estrogens—osteoporosis	0.000319	0.00278	CcSEcCtD
Carbinoxamine—Constipation—Zoledronate—osteoporosis	0.000319	0.00278	CcSEcCtD
Carbinoxamine—Nausea—Alendronate—osteoporosis	0.000318	0.00277	CcSEcCtD
Carbinoxamine—Vertigo—Estradiol—osteoporosis	0.000317	0.00276	CcSEcCtD
Carbinoxamine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000316	0.00276	CcSEcCtD
Carbinoxamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000316	0.00276	CcSEcCtD
Carbinoxamine—Nausea—Raloxifene—osteoporosis	0.000313	0.00273	CcSEcCtD
Carbinoxamine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000312	0.00272	CcSEcCtD
Carbinoxamine—Palpitations—Estradiol—osteoporosis	0.000311	0.00271	CcSEcCtD
Carbinoxamine—Fatigue—Conjugated Estrogens—osteoporosis	0.00031	0.0027	CcSEcCtD
Carbinoxamine—Nausea—Ibandronate—osteoporosis	0.00031	0.0027	CcSEcCtD
Carbinoxamine—Asthenia—Risedronate—osteoporosis	0.000308	0.00269	CcSEcCtD
Carbinoxamine—Feeling abnormal—Zoledronate—osteoporosis	0.000308	0.00268	CcSEcCtD
Carbinoxamine—Constipation—Conjugated Estrogens—osteoporosis	0.000307	0.00268	CcSEcCtD
Carbinoxamine—Nausea—Calcitriol—osteoporosis	0.000303	0.00264	CcSEcCtD
Carbinoxamine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000302	0.00263	CcSEcCtD
Carbinoxamine—Urticaria—Zoledronate—osteoporosis	0.000297	0.00258	CcSEcCtD
Carbinoxamine—Diarrhoea—Risedronate—osteoporosis	0.000294	0.00256	CcSEcCtD
Carbinoxamine—Asthenia—Pamidronate—osteoporosis	0.000293	0.00255	CcSEcCtD
Carbinoxamine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000292	0.00254	CcSEcCtD
Carbinoxamine—Confusional state—Estradiol—osteoporosis	0.00029	0.00253	CcSEcCtD
Carbinoxamine—Urticaria—Conjugated Estrogens—osteoporosis	0.000286	0.00249	CcSEcCtD
Carbinoxamine—Dizziness—Risedronate—osteoporosis	0.000284	0.00248	CcSEcCtD
Carbinoxamine—Tachycardia—Estradiol—osteoporosis	0.000281	0.00245	CcSEcCtD
Carbinoxamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00028	0.00244	CcSEcCtD
Carbinoxamine—Diarrhoea—Pamidronate—osteoporosis	0.00028	0.00244	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Estradiol—osteoporosis	0.000278	0.00242	CcSEcCtD
Carbinoxamine—Headache—Ethinyl Estradiol—osteoporosis	0.000276	0.00241	CcSEcCtD
Carbinoxamine—Vomiting—Risedronate—osteoporosis	0.000273	0.00238	CcSEcCtD
Carbinoxamine—Dizziness—Pamidronate—osteoporosis	0.00027	0.00235	CcSEcCtD
Carbinoxamine—Headache—Risedronate—osteoporosis	0.000269	0.00235	CcSEcCtD
Carbinoxamine—Asthenia—Zoledronate—osteoporosis	0.000268	0.00233	CcSEcCtD
Carbinoxamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000262	0.00228	CcSEcCtD
Carbinoxamine—Insomnia—Estradiol—osteoporosis	0.00026	0.00227	CcSEcCtD
Carbinoxamine—Vomiting—Pamidronate—osteoporosis	0.00026	0.00226	CcSEcCtD
Carbinoxamine—Paraesthesia—Estradiol—osteoporosis	0.000258	0.00225	CcSEcCtD
Carbinoxamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000258	0.00225	CcSEcCtD
Carbinoxamine—Headache—Pamidronate—osteoporosis	0.000256	0.00223	CcSEcCtD
Carbinoxamine—Somnolence—Estradiol—osteoporosis	0.000256	0.00223	CcSEcCtD
Carbinoxamine—Diarrhoea—Zoledronate—osteoporosis	0.000255	0.00222	CcSEcCtD
Carbinoxamine—Nausea—Risedronate—osteoporosis	0.000255	0.00222	CcSEcCtD
Carbinoxamine—Dyspepsia—Estradiol—osteoporosis	0.000253	0.00221	CcSEcCtD
Carbinoxamine—Decreased appetite—Estradiol—osteoporosis	0.00025	0.00218	CcSEcCtD
Carbinoxamine—Fatigue—Estradiol—osteoporosis	0.000248	0.00216	CcSEcCtD
Carbinoxamine—Dizziness—Zoledronate—osteoporosis	0.000247	0.00215	CcSEcCtD
Carbinoxamine—Constipation—Estradiol—osteoporosis	0.000246	0.00214	CcSEcCtD
Carbinoxamine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000246	0.00214	CcSEcCtD
Carbinoxamine—Nausea—Pamidronate—osteoporosis	0.000243	0.00211	CcSEcCtD
Carbinoxamine—Dizziness—Conjugated Estrogens—osteoporosis	0.000238	0.00207	CcSEcCtD
Carbinoxamine—Vomiting—Zoledronate—osteoporosis	0.000237	0.00207	CcSEcCtD
Carbinoxamine—Feeling abnormal—Estradiol—osteoporosis	0.000237	0.00207	CcSEcCtD
Carbinoxamine—Headache—Zoledronate—osteoporosis	0.000234	0.00204	CcSEcCtD
Carbinoxamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000229	0.00199	CcSEcCtD
Carbinoxamine—Urticaria—Estradiol—osteoporosis	0.000228	0.00199	CcSEcCtD
Carbinoxamine—Headache—Conjugated Estrogens—osteoporosis	0.000225	0.00196	CcSEcCtD
Carbinoxamine—Nausea—Zoledronate—osteoporosis	0.000222	0.00193	CcSEcCtD
Carbinoxamine—Nausea—Conjugated Estrogens—osteoporosis	0.000213	0.00186	CcSEcCtD
Carbinoxamine—Asthenia—Estradiol—osteoporosis	0.000206	0.0018	CcSEcCtD
Carbinoxamine—Diarrhoea—Estradiol—osteoporosis	0.000197	0.00171	CcSEcCtD
Carbinoxamine—Dizziness—Estradiol—osteoporosis	0.00019	0.00166	CcSEcCtD
Carbinoxamine—Vomiting—Estradiol—osteoporosis	0.000183	0.00159	CcSEcCtD
Carbinoxamine—Headache—Estradiol—osteoporosis	0.00018	0.00157	CcSEcCtD
Carbinoxamine—Nausea—Estradiol—osteoporosis	0.000171	0.00149	CcSEcCtD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.69e-06	0.00221	CbGpPWpGaD
Carbinoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.62e-06	0.00217	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—CALCA—osteoporosis	3.62e-06	0.00216	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.6e-06	0.00215	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.54e-06	0.00211	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—POMC—osteoporosis	3.43e-06	0.00205	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—POMC—osteoporosis	3.36e-06	0.00201	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	3.28e-06	0.00196	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PKM—osteoporosis	3.24e-06	0.00194	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—FDPS—osteoporosis	3.24e-06	0.00194	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PKM—osteoporosis	3.17e-06	0.0019	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—FDPS—osteoporosis	3.17e-06	0.0019	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SOST—osteoporosis	3.17e-06	0.00189	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.16e-06	0.00189	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GPD2—osteoporosis	3.07e-06	0.00184	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PGLS—osteoporosis	3.07e-06	0.00184	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PGLS—osteoporosis	3.01e-06	0.0018	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GPD2—osteoporosis	3.01e-06	0.0018	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.01e-06	0.0018	CbGpPWpGaD
Carbinoxamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.94e-06	0.00176	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—POMC—osteoporosis	2.91e-06	0.00174	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.88e-06	0.00172	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTH1R—osteoporosis	2.86e-06	0.00171	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CALCR—osteoporosis	2.86e-06	0.00171	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ATIC—osteoporosis	2.81e-06	0.00168	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PNP—osteoporosis	2.81e-06	0.00168	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PTH—osteoporosis	2.8e-06	0.00168	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ATIC—osteoporosis	2.75e-06	0.00164	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PNP—osteoporosis	2.75e-06	0.00164	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—FDPS—osteoporosis	2.74e-06	0.00164	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PKM—osteoporosis	2.74e-06	0.00164	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CNR2—osteoporosis	2.73e-06	0.00163	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.68e-06	0.0016	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPD2—osteoporosis	2.6e-06	0.00155	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PGLS—osteoporosis	2.6e-06	0.00155	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.6e-06	0.00155	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—POMC—osteoporosis	2.59e-06	0.00155	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.56e-06	0.00153	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PTH—osteoporosis	2.55e-06	0.00152	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.49e-06	0.00149	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CNR2—osteoporosis	2.48e-06	0.00148	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PKM—osteoporosis	2.45e-06	0.00146	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—FDPS—osteoporosis	2.45e-06	0.00146	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.45e-06	0.00146	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—OXCT1—osteoporosis	2.39e-06	0.00143	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CA2—osteoporosis	2.39e-06	0.00143	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—POMC—osteoporosis	2.39e-06	0.00143	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ATIC—osteoporosis	2.38e-06	0.00142	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PNP—osteoporosis	2.38e-06	0.00142	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—POMC—osteoporosis	2.37e-06	0.00141	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CA2—osteoporosis	2.34e-06	0.0014	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—OXCT1—osteoporosis	2.34e-06	0.0014	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—WNT1—osteoporosis	2.33e-06	0.0014	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MGLL—osteoporosis	2.33e-06	0.00139	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PTHLH—osteoporosis	2.32e-06	0.00139	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PGLS—osteoporosis	2.32e-06	0.00139	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPD2—osteoporosis	2.32e-06	0.00139	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MGLL—osteoporosis	2.28e-06	0.00136	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MGLL—osteoporosis	2.28e-06	0.00136	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—FDPS—osteoporosis	2.25e-06	0.00135	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PKM—osteoporosis	2.25e-06	0.00135	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—FDPS—osteoporosis	2.23e-06	0.00133	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PKM—osteoporosis	2.23e-06	0.00133	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LRP5—osteoporosis	2.22e-06	0.00133	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PGLS—osteoporosis	2.13e-06	0.00128	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPD2—osteoporosis	2.13e-06	0.00128	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LRP6—osteoporosis	2.12e-06	0.00127	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PNP—osteoporosis	2.12e-06	0.00127	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ATIC—osteoporosis	2.12e-06	0.00127	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PGLS—osteoporosis	2.11e-06	0.00126	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPD2—osteoporosis	2.11e-06	0.00126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PTHLH—osteoporosis	2.11e-06	0.00126	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CALCA—osteoporosis	2.05e-06	0.00122	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—OXCT1—osteoporosis	2.02e-06	0.00121	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CA2—osteoporosis	2.02e-06	0.00121	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—IDH2—osteoporosis	1.98e-06	0.00118	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MGLL—osteoporosis	1.97e-06	0.00118	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PNP—osteoporosis	1.95e-06	0.00117	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ATIC—osteoporosis	1.95e-06	0.00117	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—IDH2—osteoporosis	1.94e-06	0.00116	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ATIC—osteoporosis	1.93e-06	0.00116	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PNP—osteoporosis	1.93e-06	0.00116	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—POMC—osteoporosis	1.89e-06	0.00113	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP27A1—osteoporosis	1.86e-06	0.00111	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CALCA—osteoporosis	1.86e-06	0.00111	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.86e-06	0.00111	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP27A1—osteoporosis	1.82e-06	0.00109	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ACP5—osteoporosis	1.81e-06	0.00108	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CA2—osteoporosis	1.8e-06	0.00108	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—OXCT1—osteoporosis	1.8e-06	0.00108	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TLN1—osteoporosis	1.79e-06	0.00107	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ACP5—osteoporosis	1.77e-06	0.00106	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MGLL—osteoporosis	1.76e-06	0.00105	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—TPI1—osteoporosis	1.68e-06	0.00101	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—IDH2—osteoporosis	1.67e-06	0.001	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.66e-06	0.000992	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CA2—osteoporosis	1.66e-06	0.000992	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.66e-06	0.000991	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—TPI1—osteoporosis	1.65e-06	0.000985	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—OXCT1—osteoporosis	1.64e-06	0.000983	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CA2—osteoporosis	1.64e-06	0.000983	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MGLL—osteoporosis	1.62e-06	0.000967	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MGLL—osteoporosis	1.6e-06	0.000958	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—P4HB—osteoporosis	1.58e-06	0.000945	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.57e-06	0.000941	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.56e-06	0.000933	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GAPDH—osteoporosis	1.55e-06	0.000928	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—P4HB—osteoporosis	1.55e-06	0.000926	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—P4HB—osteoporosis	1.55e-06	0.000925	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ACP5—osteoporosis	1.53e-06	0.000916	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GAPDH—osteoporosis	1.52e-06	0.000909	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.51e-06	0.000904	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—RAP1A—osteoporosis	1.51e-06	0.000904	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.51e-06	0.000904	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTH—osteoporosis	1.5e-06	0.0009	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—IDH2—osteoporosis	1.49e-06	0.000894	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—RAP1A—osteoporosis	1.48e-06	0.000885	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RAP1A—osteoporosis	1.48e-06	0.000884	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FDPS—osteoporosis	1.47e-06	0.00088	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PKM—osteoporosis	1.47e-06	0.00088	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CNR2—osteoporosis	1.47e-06	0.000877	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.46e-06	0.000873	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	1.46e-06	0.00087	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NFATC1—osteoporosis	1.44e-06	0.000863	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—DKK1—osteoporosis	1.43e-06	0.000856	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—TPI1—osteoporosis	1.42e-06	0.000851	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.41e-06	0.00084	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPD2—osteoporosis	1.39e-06	0.000834	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PGLS—osteoporosis	1.39e-06	0.000834	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—WNT1—osteoporosis	1.38e-06	0.000824	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—IDH2—osteoporosis	1.37e-06	0.000822	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ACP5—osteoporosis	1.37e-06	0.000817	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—IDH2—osteoporosis	1.36e-06	0.000815	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.35e-06	0.000807	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGA—osteoporosis	1.34e-06	0.000802	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—P4HB—osteoporosis	1.34e-06	0.0008	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	1.32e-06	0.00079	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GAPDH—osteoporosis	1.31e-06	0.000786	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.29e-06	0.000773	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.28e-06	0.000766	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—RAP1A—osteoporosis	1.28e-06	0.000765	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PNP—osteoporosis	1.28e-06	0.000763	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ATIC—osteoporosis	1.28e-06	0.000763	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—TPI1—osteoporosis	1.27e-06	0.00076	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ACP5—osteoporosis	1.26e-06	0.000752	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTHLH—osteoporosis	1.25e-06	0.000745	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BMP2—osteoporosis	1.25e-06	0.000745	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ACP5—osteoporosis	1.25e-06	0.000745	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.23e-06	0.000736	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ENO1—osteoporosis	1.22e-06	0.000731	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGB—osteoporosis	1.22e-06	0.00073	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PSMA2—osteoporosis	1.2e-06	0.00072	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PSMA5—osteoporosis	1.2e-06	0.00072	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ENO1—osteoporosis	1.2e-06	0.000716	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—P4HB—osteoporosis	1.19e-06	0.000714	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PSMA2—osteoporosis	1.18e-06	0.000705	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PSMA5—osteoporosis	1.18e-06	0.000705	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PSMA5—osteoporosis	1.18e-06	0.000704	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PSMA2—osteoporosis	1.18e-06	0.000704	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.17e-06	0.000701	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TPI1—osteoporosis	1.17e-06	0.000699	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TPI1—osteoporosis	1.16e-06	0.000693	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.14e-06	0.000683	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.12e-06	0.000667	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—P4HB—osteoporosis	1.1e-06	0.000657	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CALCA—osteoporosis	1.1e-06	0.000656	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—P4HB—osteoporosis	1.09e-06	0.000651	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CA2—osteoporosis	1.08e-06	0.000649	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.08e-06	0.000649	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.08e-06	0.000645	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.07e-06	0.00064	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.07e-06	0.000639	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MGLL—osteoporosis	1.06e-06	0.000632	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.05e-06	0.000628	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.04e-06	0.000623	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ENO1—osteoporosis	1.03e-06	0.000619	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PSMA5—osteoporosis	1.02e-06	0.00061	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PSMA2—osteoporosis	1.02e-06	0.00061	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KL—osteoporosis	9.97e-07	0.000596	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.96e-07	0.000596	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP19A1—osteoporosis	9.77e-07	0.000584	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—POMC—osteoporosis	9.72e-07	0.000581	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP19A1—osteoporosis	9.57e-07	0.000572	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6R—osteoporosis	9.48e-07	0.000567	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ENO1—osteoporosis	9.23e-07	0.000552	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PSMA2—osteoporosis	9.1e-07	0.000544	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PSMA5—osteoporosis	9.1e-07	0.000544	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.08e-07	0.000543	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—IDH2—osteoporosis	8.99e-07	0.000537	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ENO1—osteoporosis	8.49e-07	0.000508	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.45e-07	0.000505	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ENO1—osteoporosis	8.42e-07	0.000503	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PSMA5—osteoporosis	8.37e-07	0.0005	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PSMA2—osteoporosis	8.37e-07	0.0005	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PSMA2—osteoporosis	8.3e-07	0.000496	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PSMA5—osteoporosis	8.3e-07	0.000496	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP19A1—osteoporosis	8.27e-07	0.000494	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ACP5—osteoporosis	8.22e-07	0.000492	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ADCY5—osteoporosis	7.98e-07	0.000477	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GPX1—osteoporosis	7.95e-07	0.000476	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ADCY5—osteoporosis	7.82e-07	0.000467	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADCY5—osteoporosis	7.81e-07	0.000467	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GPX1—osteoporosis	7.79e-07	0.000466	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TPI1—osteoporosis	7.64e-07	0.000457	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SPP1—osteoporosis	7.55e-07	0.000452	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP19A1—osteoporosis	7.38e-07	0.000441	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—osteoporosis	7.34e-07	0.000439	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—osteoporosis	7.19e-07	0.00043	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—P4HB—osteoporosis	7.19e-07	0.00043	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GAPDH—osteoporosis	7.05e-07	0.000422	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—RAP1A—osteoporosis	6.87e-07	0.000411	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS2—osteoporosis	6.83e-07	0.000408	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP19A1—osteoporosis	6.79e-07	0.000406	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ADCY5—osteoporosis	6.76e-07	0.000404	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GPX1—osteoporosis	6.73e-07	0.000403	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.73e-07	0.000402	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—osteoporosis	6.69e-07	0.0004	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ESR1—osteoporosis	6.38e-07	0.000382	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—osteoporosis	6.21e-07	0.000372	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ADCY5—osteoporosis	6.03e-07	0.000361	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GPX1—osteoporosis	6.01e-07	0.000359	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS1—osteoporosis	5.96e-07	0.000357	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—POMC—osteoporosis	5.87e-07	0.000351	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—POMC—osteoporosis	5.75e-07	0.000344	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—POMC—osteoporosis	5.74e-07	0.000343	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6R—osteoporosis	5.6e-07	0.000335	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ENO1—osteoporosis	5.55e-07	0.000332	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ADCY5—osteoporosis	5.55e-07	0.000332	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—osteoporosis	5.55e-07	0.000332	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GPX1—osteoporosis	5.53e-07	0.000331	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—osteoporosis	5.52e-07	0.00033	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ADCY5—osteoporosis	5.5e-07	0.000329	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GPX1—osteoporosis	5.48e-07	0.000328	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PSMA2—osteoporosis	5.47e-07	0.000327	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PSMA5—osteoporosis	5.47e-07	0.000327	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—osteoporosis	5.1e-07	0.000305	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—osteoporosis	5.06e-07	0.000302	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—POMC—osteoporosis	4.97e-07	0.000297	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.44e-07	0.000265	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—POMC—osteoporosis	4.44e-07	0.000265	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—osteoporosis	4.22e-07	0.000253	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—POMC—osteoporosis	4.08e-07	0.000244	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—POMC—osteoporosis	4.05e-07	0.000242	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.63e-07	0.000217	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPX1—osteoporosis	3.61e-07	0.000216	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.34e-07	0.000199	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—osteoporosis	3.32e-07	0.000198	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—osteoporosis	3.31e-07	0.000198	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—POMC—osteoporosis	2.67e-07	0.00016	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—osteoporosis	2.5e-07	0.000149	CbGpPWpGaD
